Ethylnorepinephrine

Drug profile

Key facts

Ethylnorepinephrine is a drug catalogued in DrugCentral. Recorded indications include Acute exacerbation of asthma, Asthma, Asthma management and Bronchiectasis.

• Indications: Acute exacerbation of asthma, Asthma, Asthma management, Bronchiectasis and Bronchitis and others.
• Molecular formula: C10H15NO3; molecular weight 197.23 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (6)

• Acute exacerbation of asthma
• Asthma
• Asthma management
• Bronchiectasis
• Bronchitis
• Pulmonary emphysema

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Ethylnorepinephrine is on its molecule page.

• Molecular formula: C₁₀H₁₅NO₃
• Molecular weight: 197.23 g/mol
• CAS number: —
• InChIKey: LENNRXOJHWNHSD-UHFFFAOYSA-N
• PubChem CID: 18538

CCC(N)C(O)C1=CC(O)=C(O)C=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Ethylnorepinephrine used for?

DrugCentral lists the following indications for Ethylnorepinephrine: Acute exacerbation of asthma, Asthma, Asthma management, Bronchiectasis, Bronchitis and Pulmonary emphysema.

What is the chemical formula of Ethylnorepinephrine?

Ethylnorepinephrine has the molecular formula C10H15NO3 and a molecular weight of 197.23 g/mol.

Sources

• DrugCentral drug card 3208 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL1322824 — compound record and bioactivity
• PubChem CID 18538 — chemical identifiers
• FDA UNII M6AY4VCZ0A — substance identity

How this page is built: methodology · editorial policy & corrections.